| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Feb―21 |
Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study |
Abigail Schulz, Natalie Huynh, Margaret Heger, Mustafa Bakir |
| 2 |
[GO] |
2023―Oct―28 |
B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C) |
Adam Klocperk, Marketa Bloomfield, Zuzana Parackova, Ludovic Aillot, Jiri Fremuth, Lumir Sasek, et al. (+7) Jan David, Filip Fencl, Aneta Skotnicova, Katerina Rejlova, Martin Magner, Ondrej Hrusak, Anna Sediva |
| 3 |
[GO] |
2023―Sep―12 |
Characterization of adolescents with functional respiratory disorders and prior history of SARS-CoV-2 |
Sebastian Felix Nepomuk Bode, Anja Schwender, Monika Toth, Christine Kaeppler-Schorn, Ute Siebeneich, Joachim Freihorst, et al. (+2) Ales Janda, Dorit Fabricius |
| 4 |
[GO] |
2021―Apr―24 |
Combined RT-qPCR and pyrosequencing of a Spike glycoprotein polybasic cleavage motif can uncover pediatric SARS-CoV-2 infections associated with heterogeneous presentation |
Patrick Philipp Weil, Jacqueline Hentschel, Frank Schult, Anton Pembaur, Beniam Ghebremedhin, Olivier Mboma, et al. (+7) Andreas Heusch, Anna-Christin Reuter, Daniel Müller, Stefan Wirth, Malik Aydin, Andreas C. W. Jenke, Jan Postberg |
|
